Semaglutide is a part of a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, and theyre used to treat diabetes and weight loss by interacting with the hunger part of the brain to suppress the appetite, and lowering blood sugar and A1C
Rather than looking at a single marker, our panels look at how different systems in your body interact
When combined, the two therapies appear to work synergistically for greater weight loss
Fact: High doses might have negative effects on the body
Most patients experience significant relief within 68 weeks without stopping treatment
Severe stomach pain may feel sharp, deep, or continuous and does not settle with time, rest, or dietary changes